莎普爱思(603168.SH)：获得盐酸奥布卡因滴眼液《药品注册证书》

Core Viewpoint - The company, Shapuaisi (603168.SH), has received the drug registration certificate for Oubukain Hydrochloride Eye Drops from the National Medical Products Administration, indicating a significant advancement in its product offerings in the ophthalmology field [1] Group 1 - The approved Oubukain Hydrochloride Eye Drops are intended for surface anesthesia in ophthalmology [1]